Early perfusion #AmyloidPET shows great potential for diagnosing and monitoring neurodegenerative disease and may have advantages over FDG-PET, #EANM authors say. buff.ly/ByQwHG6 #NucMed #radiology

We still need your input for our our survey about #AmyloidPET imaging across Europe! 🧠

⏰ Participate by July 14 (deadline extended)

Find out more below 👇

EANM - Amyloid PET survey We invite you to participate in a brief survey aimed at improving the reimbursement of amyloid PET imaging across Europe. Your input is highly valuable and will help inform efforts to enhance access to this important diagnostic tool. The survey consists of only  11 questions . It will take approximately  2 to 4 minutes  to complete, Your responses will contribute directly to shaping future policy and reimbursement frameworks. The survey is aimed at the direction of nuclear medicine facilities (delegation is possible) and refers exclusively to routine clinical examinations (no research applications). The questions refer to the current, routine situation in your facility. Multiple answers are possible. Otherwise, only one answer should be provided. The questionnaires will be collected by the EANM and analyzed by the research group of Igor Yakushev, Technical University of Munich, Germany. The questionnaires will not be passed on to other persons, institutions, or companies. Results of the survey will be published in cumulative/statistical form (mean values, standard deviation, p-values, etc.). Participants of the survey or institutions will not be named. Responses of individual institutions will not be published. After the publication of the results, all questionnaires will be deleted. Until the time of publication, each participant can withdraw the questionnaire without providing any reason. Thank you in advance for your time and support!   EANM - Amyloid PET survey We invite you to participate in a brief survey aimed at improving the reimbursement of amyloid PET imaging across Europe. Your input is highly valuable and will help inform efforts to enhance access to this important diagnostic tool. The survey consists of only  11 questions . It will take approximately  2 to 4 minutes  to complete, Your responses will contribute directly to shaping future policy and reimbursement frameworks. The survey is aimed at the direction of nuclear medicine facilities (delegation is possible) and refers exclusively to routine clinical examinations (no research applications). The questions refer to the current, routine situation in your facility. Multiple answers are possible. Otherwise, only one answer should be provided. The questionnaires will be collected by the EANM and analyzed by the research group of Igor Yakushev, Technical University of Munich, Germany. The questionnaires will not be passed on to other persons, institutions, or companies. Results of the survey will be published in cumulative/statistical form (mean values, standard deviation, p-values, etc.). Participants of the survey or institutions will not be named. Responses of individual institutions will not be published. After the publication of the results, all questionnaires will be deleted. Until the time of publication, each participant can withdraw the questionnaire without providing any reason. Thank you in advance for your time and support!  

Take part in our survey about #AmyloidPET imaging across Europe! 🧠

📝 Just 11 questions – takes 2–4 minutes
🔒 Fully confidential – no institutions or individuals will be named
📈 Results will be published in aggregated statistical form

👉 committeemeeting.questionpro.com/t/AKfvuZ6GAA

So proud of and grateful for present and past @hwameeohlab.bsky.social members and collaborators who made us become the #FIRST lab to perform #amyloidPET and #tauPET scans through Brown University !